Pharmaceutical Cybersecurity Success: Haleon's Zero-Downtime Microsegmentation with Elisity

How a Global Pharmaceutical Leader Achieved Enterprise Security Without Operational Disruption

Edmond Mack, CISO at Haleon, faced the critical challenge of advancing pharmaceutical cybersecurity for a global company where any network disruption could impact life-sustaining medications. In pharmaceutical cybersecurity, where "the off switch means people die," Mack needed a microsegmentation solution that could enhance security without compromising business continuity. Elisity's identity-based microsegmentation platform delivered exactly that—enabling Haleon to secure their users, workloads, and devices while maintaining the operational excellence essential to pharmaceutical distribution and healthcare delivery.

Seamless Implementation: Redefining Pharmaceutical Cybersecurity Standards

The pharmaceutical cybersecurity implementation results exceeded expectations, demonstrating Elisity's ability to deploy enterprise-wide microsegmentation without the traditional risks that plague healthcare and pharmaceutical security projects. "One of the things I'm most proud about as we went through the Elisity deployment as we had no P ones, no outages, deploying in the environment without hurting the business or causing any inverse effects," Mack explains. This seamless deployment using Haleon's existing network infrastructure eliminated the complexity and disruption typically associated with pharmaceutical cybersecurity microsegmentation projects, allowing the security team to prevent lateral movement while maintaining business velocity critical to patient care.

Scaling Pharmaceutical Cybersecurity at Enterprise Speed

Beyond operational success, Elisity transformed how Haleon approaches pharmaceutical cybersecurity scalability across their global operations. The platform's dynamic policy engine and comprehensive visibility into IT, IoT, and OT environments enabled rapid expansion of security controls essential for pharmaceutical cybersecurity compliance and risk reduction. As Mack notes, "Our ability to scale policy deployment across the business enables the business to expand and scale at speed." This combination of enhanced pharmaceutical cybersecurity posture and business enablement positioned Haleon to achieve Zero Trust maturity while protecting critical pharmaceutical operations and patient safety worldwide.

Ready to revolutionize your pharmaceutical cybersecurity strategy? Watch Edmond's full case study video and schedule a consultation to discover how identity-based microsegmentation can secure your organization's users, workloads, and devices from lateral movement while accelerating your Zero Trust journey without downtime. Schedule a demo now.